Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
1.14M
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$760K
-
Value change
-
-$1.03M
-
Number of buys
-
6
-
Number of sells
-
-11
-
Price
-
$0.67
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2025
23 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q3 2025.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.14M shares
of 29M outstanding shares and own 3.93% of the company stock.
Largest 10 shareholders include Squarepoint Ops LLC (444K shares), Apollon Financial, LLC (250K shares), OneDigital Investment Advisors LLC (191K shares), RENAISSANCE TECHNOLOGIES LLC (81.7K shares), Virtu Financial LLC (47.1K shares), Krilogy Financial LLC (40K shares), SG Americas Securities, LLC (16.8K shares), JANE STREET GROUP, LLC (14.5K shares), GEODE CAPITAL MANAGEMENT, LLC (12.4K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.7K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.